ICICI BANK LTD-SPON ADR (IBN)

US45104G1040 - ADR

30.3  +0.23 (+0.76%)

After market: 30.3 0 (0%)

Fundamental Rating

4

IBN gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 406 industry peers in the Banks industry. There are concerns on the financial health of IBN while its profitability can be described as average. IBN is valued quite expensively, but it does show have an excellent growth rating.



4

1. Profitability

1.1 Basic Checks

In the past year IBN was profitable.
In the past year IBN had a positive cash flow from operations.
In the past 5 years IBN has always been profitable.
Of the past 5 years IBN 4 years had a positive operating cash flow.

1.2 Ratios

With an excellent Return On Assets value of 1.88%, IBN belongs to the best of the industry, outperforming 95.30% of the companies in the same industry.
With an excellent Return On Equity value of 16.91%, IBN belongs to the best of the industry, outperforming 95.54% of the companies in the same industry.
Industry RankSector Rank
ROA 1.88%
ROE 16.91%
ROIC N/A
ROA(3y)1.68%
ROA(5y)1.38%
ROE(3y)15.65%
ROE(5y)13.28%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

IBN has a better Profit Margin (25.79%) than 67.82% of its industry peers.
In the last couple of years the Profit Margin of IBN has grown nicely.
IBN does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 25.79%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y20.83%
PM growth 5Y42.71%
GM growth 3YN/A
GM growth 5YN/A

3

2. Health

2.1 Basic Checks

IBN does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, IBN has more shares outstanding
Compared to 5 years ago, IBN has more shares outstanding
IBN has a better debt/assets ratio than last year.

2.2 Solvency

The Debt to FCF ratio of IBN is 1.11, which is an excellent value as it means it would take IBN, only 1.11 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of IBN (1.11) is better than 76.98% of its industry peers.
IBN has a Debt/Equity ratio of 0.78. This is a neutral value indicating IBN is somewhat dependend on debt financing.
IBN has a Debt to Equity ratio of 0.78. This is amonst the worse of the industry: IBN underperforms 83.42% of its industry peers.
Although IBN does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 0.78
Debt/FCF 1.11
Altman-Z N/A
ROIC/WACCN/A
WACC8.64%

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 16.66% over the past year.
Measured over the past years, IBN shows a very strong growth in Earnings Per Share. The EPS has been growing by 61.93% on average per year.
The Revenue has grown by 22.93% in the past year. This is a very strong growth!
IBN shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.94% yearly.
EPS 1Y (TTM)16.66%
EPS 3Y34.49%
EPS 5Y61.93%
EPS Q2Q%13.7%
Revenue 1Y (TTM)22.93%
Revenue growth 3Y10.91%
Revenue growth 5Y11.94%
Sales Q2Q%9.5%

3.2 Future

The Earnings Per Share is expected to grow by 13.62% on average over the next years. This is quite good.
The Revenue is expected to grow by 25.56% on average over the next years. This is a very strong growth
EPS Next Y14.7%
EPS Next 2Y13.16%
EPS Next 3Y13.62%
EPS Next 5YN/A
Revenue Next Year11.84%
Revenue Next 2Y12.78%
Revenue Next 3Y25.56%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

3

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 20.75, IBN is valued on the expensive side.
Based on the Price/Earnings ratio, IBN is valued a bit more expensive than the industry average as 77.72% of the companies are valued more cheaply.
IBN's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.73.
A Price/Forward Earnings ratio of 17.25 indicates a rather expensive valuation of IBN.
Compared to the rest of the industry, the Price/Forward Earnings ratio of IBN indicates a slightly more expensive valuation: IBN is more expensive than 73.76% of the companies listed in the same industry.
IBN's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.83.
Industry RankSector Rank
PE 20.75
Fwd PE 17.25

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, IBN is valued cheaply inside the industry as 91.83% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 4.58
EV/EBITDA N/A

4.3 Compensation for Growth

IBN's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
IBN's earnings are expected to grow with 13.62% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.41
PEG (5Y)0.34
EPS Next 2Y13.16%
EPS Next 3Y13.62%

3

5. Dividend

5.1 Amount

IBN has a yearly dividend return of 0.78%, which is pretty low.
With a Dividend Yield of 0.78, IBN pays less dividend than the industry average, which is at 3.15. 82.92% of the companies listed in the same industry pay a better dividend than IBN!
Compared to an average S&P500 Dividend Yield of 2.34, IBN's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.78%

5.2 History

On average, the dividend of IBN grows each year by 34.51%, which is quite nice.
IBN has been paying a dividend for at least 10 years, so it has a reliable track record.
IBN has decreased its dividend recently.
Dividend Growth(5Y)34.51%
Div Incr Years1
Div Non Decr Years1

5.3 Sustainability

14.87% of the earnings are spent on dividend by IBN. This is a low number and sustainable payout ratio.
IBN's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP14.87%
EPS Next 2Y13.16%
EPS Next 3Y13.62%

ICICI BANK LTD-SPON ADR

NYSE:IBN (12/20/2024, 8:17:43 PM)

After market: 30.3 0 (0%)

30.3

+0.23 (+0.76%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)10-26 2024-10-26/dmh
Earnings (Next)01-18 2025-01-18
Inst Owners54.36%
Inst Owner Change-2.64%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap106.92B
Analysts87.44
Price Target34.93 (15.28%)
Short Float %0.44%
Short Ratio6.03
Dividend
Industry RankSector Rank
Dividend Yield 0.78%
Dividend Growth(5Y)34.51%
DP14.87%
Div Incr Years1
Div Non Decr Years1
Ex-Date08-12 2024-08-12 (10)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)4.14%
Min EPS beat(2)3.55%
Max EPS beat(2)4.73%
EPS beat(4)4
Avg EPS beat(4)3.81%
Min EPS beat(4)2.68%
Max EPS beat(4)4.73%
EPS beat(8)6
Avg EPS beat(8)2.53%
EPS beat(12)8
Avg EPS beat(12)2.03%
EPS beat(16)10
Avg EPS beat(16)1.29%
Revenue beat(2)0
Avg Revenue beat(2)-2.86%
Min Revenue beat(2)-4.62%
Max Revenue beat(2)-1.11%
Revenue beat(4)1
Avg Revenue beat(4)6.64%
Min Revenue beat(4)-4.62%
Max Revenue beat(4)32.9%
Revenue beat(8)4
Avg Revenue beat(8)34.19%
Revenue beat(12)8
Avg Revenue beat(12)67.11%
Revenue beat(16)12
Avg Revenue beat(16)95.75%
PT rev (1m)3.68%
PT rev (3m)3.66%
EPS NQ rev (1m)-0.17%
EPS NQ rev (3m)1.45%
EPS NY rev (1m)-0.17%
EPS NY rev (3m)1.34%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-25.4%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.47%
Valuation
Industry RankSector Rank
PE 20.75
Fwd PE 17.25
P/S 4.95
P/FCF 4.58
P/OCF 4.48
P/B 3.25
P/tB 3.28
EV/EBITDA N/A
EPS(TTM)1.46
EY4.82%
EPS(NY)1.76
Fwd EY5.8%
FCF(TTM)6.61
FCFY21.82%
OCF(TTM)6.76
OCFY22.32%
SpS6.12
BVpS9.33
TBVpS9.24
PEG (NY)1.41
PEG (5Y)0.34
Profitability
Industry RankSector Rank
ROA 1.88%
ROE 16.91%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 25.79%
GM N/A
FCFM 107.99%
ROA(3y)1.68%
ROA(5y)1.38%
ROE(3y)15.65%
ROE(5y)13.28%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y20.83%
PM growth 5Y42.71%
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.07
Health
Industry RankSector Rank
Debt/Equity 0.78
Debt/FCF 1.11
Debt/EBITDA N/A
Cap/Depr 178.4%
Cap/Sales 2.49%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 418.79%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score6
WACC8.64%
ROIC/WACCN/A
Cap/Depr(3y)153.33%
Cap/Depr(5y)142.3%
Cap/Sales(3y)1.9%
Cap/Sales(5y)1.78%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)16.66%
EPS 3Y34.49%
EPS 5Y61.93%
EPS Q2Q%13.7%
EPS Next Y14.7%
EPS Next 2Y13.16%
EPS Next 3Y13.62%
EPS Next 5YN/A
Revenue 1Y (TTM)22.93%
Revenue growth 3Y10.91%
Revenue growth 5Y11.94%
Sales Q2Q%9.5%
Revenue Next Year11.84%
Revenue Next 2Y12.78%
Revenue Next 3Y25.56%
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y1050.95%
FCF growth 3Y4.23%
FCF growth 5Y26.57%
OCF growth 1Y1177.87%
OCF growth 3Y4.62%
OCF growth 5Y26.56%